TLR8 rs3761624: Understanding the p53-Responsive Variant
The rs3761624 variant is a single nucleotide polymorphism located in the promoter region of the TLR8 gene. Research indicates this variant influences how the gene responds to p53 activation, potentially modulating inflammatory responses following DNA damage.
What each genotype means
Reduced TLR8 expression
This genotype is associated with reduced p53 binding to the TLR8 promoter, which may lead to lower TLR8 mRNA and protein expression levels following p53 activation. Research suggests this variant may influence the innate immune response to certain respiratory infections, though individual outcomes vary significantly.
This is the major allele genotype in many populations, though specific frequency data varies by ancestry.
Intermediate TLR8 expression
Carrying one copy of the G allele allows for p53-responsive regulation of the TLR8 gene. This genotype may result in an intermediate level of TLR8 expression compared to those with the AA or GG genotypes when the p53 pathway is activated by cellular stress or infection.
This heterozygous genotype is commonly observed in diverse populations.
Enhanced TLR8 expression
The G allele is part of a functional p53 response element, and this genotype is associated with enhanced TLR8 expression in response to p53 activation. Studies have linked this allele to differences in the severity of respiratory syncytial virus (RSV) infections in infants, suggesting a role in modulating the innate immune response.
The G allele is the minor allele, making this homozygous genotype less common than the AA or AG configurations in most studied populations.
What is rs3761624 and Where is it Located?
The variant rs3761624 is a specific genetic change located within the promoter region of the TLR8 gene, situated on the X chromosome. Specifically, it resides within a p53-responsive element (p53RE) located approximately 1 kilobase upstream of the gene's transcription start site. In genetics, a promoter is a region of DNA that initiates the transcription of a particular gene. By sitting within a p53-responsive element, this SNP acts as a regulatory switch. The presence of different alleles at this position can alter the binding affinity of the p53 protein, a critical tumor suppressor that responds to cellular stress. Because this variant is located in a regulatory sequence rather than the protein-coding portion of the gene, it does not change the structure of the TLR8 protein itself, but rather influences the quantity of TLR8 mRNA produced under specific conditions, such as during DNA damage or cellular stress.
The Role of the TLR8 Gene
The TLR8 gene encodes Toll-like receptor 8, a protein that plays a vital role in the innate immune system. TLR8 is primarily located within endosomes, which are small compartments inside immune cells. Its main function is to detect foreign single-stranded RNA, such as that found in certain viruses like HIV-1 or SARS-CoV-2. When TLR8 recognizes these viral signatures, it dimerizes and recruits a signaling molecule called MYD88. This triggers a cascade of events, including the activation of NF-κB and IRF signaling pathways, which ultimately leads to the production of pro-inflammatory cytokines and type I interferons. This process is essential for bridging the gap between innate and adaptive immunity, helping the body mount an effective defense against intracellular pathogens. Because of its role in inflammation, TLR8 is also a subject of interest in studies regarding autoimmune conditions and cancer immunology.
Research Associations and Evidence Strength
The evidence linking rs3761624 to biological function is considered moderate and is primarily focused on its role in the p53-mediated stress response. Published research has demonstrated that the minor G allele of this SNP is responsive to p53 activation, whereas the A allele disrupts the CWWG core sequence, thereby reducing p53 binding. This interaction is significant because it suggests that individuals with different genotypes may exhibit varying levels of TLR8 expression when their cells undergo acute or chronic DNA damage, such as that induced by certain chemotherapeutic agents. While these findings provide a clear mechanistic link in laboratory settings using primary T lymphocytes and alveolar macrophages, the clinical implications for human health remain an area of active investigation. It is important to note that while this variant is a target of interest in inflammatory research, it is not currently used as a standard diagnostic tool for clinical decision-making.
What You Can and Cannot Do With This Information
Understanding your genotype for rs3761624 provides insight into the regulatory mechanisms of your immune system, specifically regarding how your cells might respond to stress. However, it is crucial to recognize that this information is for educational purposes only. You cannot use this data to diagnose yourself with an immune disorder or to predict your personal response to specific medical treatments. Genetic variants often work in concert with many other factors, including environmental exposures, lifestyle, and other genetic markers, to influence health outcomes. If you are undergoing medical treatment, such as chemotherapy, or if you have concerns about your immune health, you should always discuss your medical history and any genetic testing results with your clinician or pharmacist. They are the only ones qualified to interpret how such information might relate to your specific clinical situation and to guide your care accordingly.
How common is this variant?
Specific population frequency data for rs3761624 is not widely documented in standard public catalogs, and frequency may vary significantly across different ancestral groups.
Frequently asked questions
What does the TLR8 gene do?
TLR8 is a protein that helps the immune system detect foreign single-stranded RNA from viruses. It triggers inflammatory responses to help the body fight off infections.
Is rs3761624 a disease-causing mutation?
No, rs3761624 is a common genetic variant, not a disease-causing mutation. It is a regulatory SNP that may influence how the TLR8 gene is expressed under stress.
Can I use this SNP to predict my response to chemotherapy?
No. While research shows this SNP affects TLR8 expression during DNA damage, it is not a clinical test for chemotherapy response. Always consult your oncologist regarding your treatment plan.
Where can I find more information about my specific genotype?
You can discuss your genetic reports with a certified genetic counselor or your primary care physician. They can help you understand the context of your results.
Sources & further reading
Educational information only, last refreshed 10/5/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs3761624?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29